SE0201940D0 - New combination II - Google Patents
New combination IIInfo
- Publication number
- SE0201940D0 SE0201940D0 SE0201940A SE0201940A SE0201940D0 SE 0201940 D0 SE0201940 D0 SE 0201940D0 SE 0201940 A SE0201940 A SE 0201940A SE 0201940 A SE0201940 A SE 0201940A SE 0201940 D0 SE0201940 D0 SE 0201940D0
- Authority
- SE
- Sweden
- Prior art keywords
- new combination
- relates
- disease
- reflux
- thrive
- Prior art date
Links
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 206010067171 Regurgitation Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 206010016165 failure to thrive Diseases 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/04—Sulfinic acids; Esters thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201940A SE0201940D0 (sv) | 2002-06-20 | 2002-06-20 | New combination II |
| ARP030102095A AR040203A1 (es) | 2002-06-20 | 2003-06-11 | Combinacion de un inhibidor del reflujo y una imidazopiridina para el tratamiento de la gerd |
| AU2003237739A AU2003237739A1 (en) | 2002-06-20 | 2003-06-16 | Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
| PCT/SE2003/001008 WO2004000856A1 (fr) | 2002-06-20 | 2003-06-16 | Combinaison d'un inhibiteur de reflux gastro-oesophagien et imidazopyridine destinee au traitement du reflux gastro-oesophagien pathologique |
| TW092116257A TW200403059A (en) | 2002-06-20 | 2003-06-16 | Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201940A SE0201940D0 (sv) | 2002-06-20 | 2002-06-20 | New combination II |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0201940D0 true SE0201940D0 (sv) | 2002-06-20 |
Family
ID=20288298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0201940A SE0201940D0 (sv) | 2002-06-20 | 2002-06-20 | New combination II |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR040203A1 (fr) |
| AU (1) | AU2003237739A1 (fr) |
| SE (1) | SE0201940D0 (fr) |
| TW (1) | TW200403059A (fr) |
| WO (1) | WO2004000856A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1736478B1 (fr) | 2000-05-26 | 2015-07-22 | IDENIX Pharmaceuticals, Inc. | Procédés et compositions de traitement des flavivirus et des pestivirus |
| WO2004105795A1 (fr) * | 2003-05-27 | 2004-12-09 | Altana Pharma Ag | Combinaisons pharmaceutiques d'un inhibiteur de la pompe a protons et d'un compose modifiant la motilite gastro-intestinale |
| WO2005077345A1 (fr) * | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Composes pour le traitement de la maladie du reflux gastro-oesophagien |
| SE0402462D0 (sv) * | 2004-10-08 | 2004-10-08 | Astrazeneca Ab | New process |
| US7494985B2 (en) | 2004-11-03 | 2009-02-24 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| US7566738B2 (en) | 2004-11-03 | 2009-07-28 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| US7585996B2 (en) | 2006-09-15 | 2009-09-08 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| JP2013518085A (ja) | 2010-02-01 | 2013-05-20 | ノバルティス アーゲー | CRF−1受容体アンタゴニストとしてのピラゾロ[5,1b]オキサゾール誘導体 |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| JP5748777B2 (ja) | 2010-02-02 | 2015-07-15 | ノバルティス アーゲー | Crf受容体アンタゴニストとしてのシクロヘキシルアミド誘導体 |
| UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
| CA2867043A1 (fr) | 2012-05-03 | 2013-11-07 | Novartis Ag | Sel de l-malate de derives de 2,7-diaza-spiro[4.5]dec-7-yle et ses formes cristallines a titre d'agonistes des recepteurs de ghreline |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
| SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| SE9904507D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
-
2002
- 2002-06-20 SE SE0201940A patent/SE0201940D0/xx unknown
-
2003
- 2003-06-11 AR ARP030102095A patent/AR040203A1/es not_active Application Discontinuation
- 2003-06-16 AU AU2003237739A patent/AU2003237739A1/en not_active Abandoned
- 2003-06-16 TW TW092116257A patent/TW200403059A/zh unknown
- 2003-06-16 WO PCT/SE2003/001008 patent/WO2004000856A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003237739A1 (en) | 2004-01-06 |
| AR040203A1 (es) | 2005-03-16 |
| WO2004000856A1 (fr) | 2003-12-31 |
| TW200403059A (en) | 2004-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0201940D0 (sv) | New combination II | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| ATE344029T1 (de) | Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern | |
| NO20045429L (no) | Kombinasjon av organiske forbindelser | |
| ATE508735T1 (de) | Pulmonale verabreichung von aminoglykosiden | |
| NO20052591L (no) | Pyridopyrolizin og pyridoindolizinderivater | |
| LTC1562603I2 (lt) | Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui | |
| CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
| NO20052512L (no) | Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander | |
| IS2696B (is) | Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð | |
| NO20070608L (no) | Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast | |
| NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
| BRPI0410467A (pt) | composições e métodos para tratamento de sìndrome respiratória aguda severa (sars) | |
| MX2007002470A (es) | Fenilaminotiazoles sustituidos y su uso. | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| NO20043115L (no) | Substituerte diketopiperaziner som oksytocin antagonister | |
| TNSN06138A1 (fr) | Inhibitors of the mutant form of kit | |
| CY1110369T1 (el) | Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη | |
| DK1973539T3 (da) | Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression | |
| DE50310038D1 (de) | Hemmstoffe der urokinase, ihre herstellung und verwendung | |
| SE0201939D0 (sv) | New combination | |
| SE0200198D0 (sv) | New use | |
| SE0301883D0 (sv) | New use II | |
| HRP20050611B1 (hr) | Kombinacijski lijek | |
| DK1532279T3 (da) | Fremgangsmåde, sammensætning og kit til antigenbinding af Norwalk-lignende vira |